Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery
about
Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery
description
clinical trial
@en
klinisch onderzoek
@nl
name
Ziv-Aflibercept in Treating an ...... r Cannot Be Removed by Surgery
@en
type
label
Ziv-Aflibercept in Treating an ...... r Cannot Be Removed by Surgery
@en
prefLabel
Ziv-Aflibercept in Treating an ...... r Cannot Be Removed by Surgery
@en
P1476
Perfusion CT as Predictive Bio ...... ncreatic Neuroendocrine Tumors
@en
P3098
NCT02101918
P580
2014-06-18T00:00:00Z
P582
2018-01-31T00:00:00Z